| HOME >> MEDICINE >> TECHNOLOGY |
4,040,054$
3,189,221$
3,037,491Liabilities and Shareholders' EquityCurrent liabilities Accounts payable$
307,017$
343,278$
286,795 Short-term debt-2,7701,180 Payroll and related taxes74,45081,45571,521 Accrued customer programs103,86891,37491,704 Accrued liabilities83,88657,51479,485 Accrued income taxes20,53010,55117,351 Current portion of long-term debt40,00015,00015,000 Current liabilities of discontinued operations -4,0933,570Total current liabilities629,751606,035566,606Non-current liabilities Long-term debt, less current portion1,454,620875,000875,442 Non-current deferred income taxes19,54310,60111,900 Other non-current liabilities163,466166,598158,444Total non-current liabilities1,637,6291,052,1991,045,786Shareholders' equity Controlling interest shareholders' equity:Preferred stock, without par value, 10,000 shares authorized ---Common stock, without par value, 200,000 shares authorized 496,320467,661458,811Accumulated other comprehensive income75,800127,050109,080Retained earnings1,198,740934,333855,2871,770,8601,529,0441,423,178 Noncontrolling interest1,8141,9431,921Total shareholders' equity1,772,6741,530,9871,425,099$
4,040,054$
3,189,221$
3,037,491Supplemental Disclosures of Balance Sheet Information Related to Continuing OperationsAllowance for doubtful accounts$
2,483$
7,837$
7,618Working capital $
1,161,137$
772,783$
693,814Preferred stock, shares issued and outstanding---Common stock, shares issued and outstanding93,40592,77892,682See accompanying notes to condensed consolidated financial st
'/>"/>
| SOURCE Perrigo Company Copyright©2010 PR Newswire. All rights reserved |